130 related articles for article (PubMed ID: 35657002)
1. Disparities in Access to Systemic Treatment for Breast Cancer in Thailand and Major Asian Territories.
Ithimakin S; Parinyanitikul N; Kim SB; Yap YS; Tsang J; Soong IS; Ozaki Y; Ohno S; Ono M; Chan JJ; Cheng HCS; Dejthevaporn T;
J Breast Cancer; 2022 Jun; 25(3):207-217. PubMed ID: 35657002
[TBL] [Abstract][Full Text] [Related]
2. The ESMO-Magnitude of Clinical Benefit Scale for novel oncology drugs: correspondence with three years of reimbursement decisions in Israel.
Hammerman A; Greenberg-Dotan S; Feldhamer I; Birnbaum Y; Cherny NI
Expert Rev Pharmacoecon Outcomes Res; 2018 Feb; 18(1):119-122. PubMed ID: 28617621
[TBL] [Abstract][Full Text] [Related]
3. Cancer medicines in Asia and Asia-Pacific: What is available, and is it effective enough?
Eniu A; Cherny NI; Bertram M; Thongprasert S; Douillard JY; Bricalli G; Vyas M; Trapani D
ESMO Open; 2019; 4(4):e000483. PubMed ID: 31423334
[TBL] [Abstract][Full Text] [Related]
4. Essential cancer medicines in the national lists of countries of the WHO South-East Asia Region: a descriptive assessment.
Chivukula MV; Tisocki K
WHO South East Asia J Public Health; 2018 Sep; 7(2):90-98. PubMed ID: 30136667
[TBL] [Abstract][Full Text] [Related]
5. Current practices and challenges in genetic testing and counseling for women with breast and ovarian cancer in Asia.
Kwong A; Tan DS; Ryu JM;
Asia Pac J Clin Oncol; 2024 May; ():. PubMed ID: 38776249
[TBL] [Abstract][Full Text] [Related]
6. Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries.
Kandolf Sekulovic L; Guo J; Agarwala S; Hauschild A; McArthur G; Cinat G; Wainstein A; Caglevic C; Lorigan P; Gogas H; Alvarez M; Duncombe R; Lebbe C; Peris K; Rutkowski P; Stratigos A; Forsea AM; De La Cruz Merino L; Kukushkina M; Dummer R; Hoeller C; Gorry C; Bastholt L; Herceg D; Neyns B; Vieira R; Arenberger P; Bylaite-Bucinskiene M; Babovic N; Banjin M; Putnik K; Todorovic V; Kirov K; Ocvirk J; Zhukavets A; Ymeri A; Stojkovski I; Garbe C
Eur J Cancer; 2018 Nov; 104():201-209. PubMed ID: 30388700
[TBL] [Abstract][Full Text] [Related]
7. Essential cancer medicines: adding feasibility to the magnitude of clinical benefit value chain.
Roitberg F; Amaral T; Cherny NI; Giuliani R; Latino NJ; Galotti M; Bricalli G; Curigliano G; Pentheroudakis G; Trapani D
ESMO Open; 2023 Oct; 8(5):101617. PubMed ID: 37672862
[TBL] [Abstract][Full Text] [Related]
8. Time to access to novel anticancer drugs and the correlation with ESMO-Magnitude of Clinical Benefit Scale in Slovenia.
Janzic U; Knez L; Janzic A; Cufer T
Expert Rev Pharmacoecon Outcomes Res; 2019 Dec; 19(6):717-723. PubMed ID: 31826655
[No Abstract] [Full Text] [Related]
9. Overall survival benefits of cancer drugs in the WHO Model List of Essential Medicines, 2015-2021.
Zhou Y; Naci H; Chen D; Bai L; Shi L; Guan X; Wagner AK
BMJ Glob Health; 2023 Sep; 8(9):. PubMed ID: 37775106
[TBL] [Abstract][Full Text] [Related]
10. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with early breast cancer.
Park KH; Loibl S; Sohn J; Park YH; Jiang Z; Tadjoedin H; Nag S; Saji S; Md Yusof M; Villegas EMB; Lim EH; Lu YS; Ithimakin S; Tseng LM; Dejthevaporn T; Chen TW; Lee SC; Galvez C; Malwinder S; Kogawa T; Bajpai J; Brahma B; Wang S; Curigliano G; Yoshino T; Kim SB; Pentheroudakis G; Im SA; Andre F; Ahn JB; Harbeck N
ESMO Open; 2024 May; 9(5):102974. PubMed ID: 38796284
[TBL] [Abstract][Full Text] [Related]
11. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with early breast cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.
Park YH; Senkus-Konefka E; Im SA; Pentheroudakis G; Saji S; Gupta S; Iwata H; Mastura MY; Dent R; Lu YS; Yin Y; Smruti BK; Toyama T; Malwinder S; Lee SC; Tseng LM; Kim JH; Kim TY; Suh KJ; Cardoso F; Yoshino T; Douillard JY
Ann Oncol; 2020 Apr; 31(4):451-469. PubMed ID: 32081575
[TBL] [Abstract][Full Text] [Related]
12. Peritoneal dialysis in Asia.
Cheng IK
Perit Dial Int; 1996; 16 Suppl 1():S381-5. PubMed ID: 8728228
[TBL] [Abstract][Full Text] [Related]
13. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with locally-advanced unresectable non-small-cell lung cancer: a KSMO-ESMO initiative endorsed by CSCO, ISMPO, JSMO, MOS, SSO and TOS.
Park K; Vansteenkiste J; Lee KH; Pentheroudakis G; Zhou C; Prabhash K; Seto T; Voon PJ; Tan DSW; Yang JCH; Wang J; Babu KG; Nakayama Y; Alip A; Chua KLM; Cheng JC; Senan S; Ahn YC; Kim TY; Ahn HK; Peters S; Yoshino T; Douillard JY
Ann Oncol; 2020 Feb; 31(2):191-201. PubMed ID: 31959336
[TBL] [Abstract][Full Text] [Related]
14. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, staging and treatment of patients with metastatic breast cancer.
Im SA; Gennari A; Park YH; Kim JH; Jiang ZF; Gupta S; Fadjari TH; Tamura K; Mastura MY; Abesamis-Tiambeng MLT; Lim EH; Lin CH; Sookprasert A; Parinyanitikul N; Tseng LM; Lee SC; Caguioa P; Singh M; Naito Y; Hukom RA; Smruti BK; Wang SS; Kim SB; Lee KH; Ahn HK; Peters S; Kim TW; Yoshino T; Pentheroudakis G; Curigliano G; Harbeck N
ESMO Open; 2023 Jun; 8(3):101541. PubMed ID: 37178669
[TBL] [Abstract][Full Text] [Related]
15. Pan-Asian adapted ESMO Clinical Practice Guidelines for the management of patients with intermediate and advanced/relapsed hepatocellular carcinoma: a TOS-ESMO initiative endorsed by CSCO, ISMPO, JSMO, KSMO, MOS and SSO.
Chen LT; Martinelli E; Cheng AL; Pentheroudakis G; Qin S; Bhattacharyya GS; Ikeda M; Lim HY; Ho GF; Choo SP; Ren Z; Malhotra H; Ueno M; Ryoo BY; Kiang TC; Tai D; Vogel A; Cervantes A; Lu SN; Yen CJ; Huang YH; Chen SC; Hsu C; Shen YC; Tabernero J; Yen Y; Hsu CH; Yoshino T; Douillard JY
Ann Oncol; 2020 Mar; 31(3):334-351. PubMed ID: 32067677
[TBL] [Abstract][Full Text] [Related]
16. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with metastatic colorectal cancer.
Yoshino T; Cervantes A; Bando H; Martinelli E; Oki E; Xu RH; Mulansari NA; Govind Babu K; Lee MA; Tan CK; Cornelio G; Chong DQ; Chen LT; Tanasanvimon S; Prasongsook N; Yeh KH; Chua C; Sacdalan MD; Sow Jenson WJ; Kim ST; Chacko RT; Syaiful RA; Zhang SZ; Curigliano G; Mishima S; Nakamura Y; Ebi H; Sunakawa Y; Takahashi M; Baba E; Peters S; Ishioka C; Pentheroudakis G
ESMO Open; 2023 Jun; 8(3):101558. PubMed ID: 37236086
[TBL] [Abstract][Full Text] [Related]
17. Evidence-based decision-making in Asia-Pacific with rapidly changing health-care systems: Thailand, South Korea, and Taiwan.
Jirawattanapisal T; Kingkaew P; Lee TJ; Yang MC
Value Health; 2009; 12 Suppl 3():S4-11. PubMed ID: 20586980
[TBL] [Abstract][Full Text] [Related]
18. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with gastric cancer.
Shitara K; Fleitas T; Kawakami H; Curigliano G; Narita Y; Wang F; Wardhani SO; Basade M; Rha SY; Wan Zamaniah WI; Sacdalan DL; Ng M; Yeh KH; Sunpaweravong P; Sirachainan E; Chen MH; Yong WP; Peneyra JL; Ibtisam MN; Lee KW; Krishna V; Pribadi RR; Li J; Lui A; Yoshino T; Baba E; Nakayama I; Pentheroudakis G; Shoji H; Cervantes A; Ishioka C; Smyth E
ESMO Open; 2024 Feb; 9(2):102226. PubMed ID: 38458658
[TBL] [Abstract][Full Text] [Related]
19. Pan-Asian adapted ESMO Clinical Practice Guidelines for the diagnosis, treatment and follow-up of patients with endometrial cancer.
Koppikar S; Oaknin A; Babu KG; Lorusso D; Gupta S; Wu LY; Rajabto W; Harano K; Hong SH; Malik RA; Strebel H; Aggarwal IM; Lai CH; Dejthevaporn T; Tangjitgamol S; Cheng WF; Chay WY; Benavides D; Hashim NM; Moon YW; Yunokawa M; Anggraeni TD; Wei W; Curigliano G; Maheshwari A; Mahantshetty U; Sheshadri S; Peters S; Yoshino T; Pentheroudakis G
ESMO Open; 2023 Feb; 8(1):100774. PubMed ID: 36696825
[TBL] [Abstract][Full Text] [Related]
20. ESMO European Consortium Study on the availability, out-of-pocket costs and accessibility of antineoplastic medicines in Europe.
Cherny N; Sullivan R; Torode J; Saar M; Eniu A
Ann Oncol; 2016 Aug; 27(8):1423-43. PubMed ID: 27457309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
